Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Disc Medicine Inc (IRON)

Disc Medicine Inc (IRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Disc Medicine Inc 321 Arsenal Street Suite 101 Watertown MA 02472 USA

www.discmedicine.com Employees: 84 P: 617-674-9274

Sector:

Medical

Description:

Disc Medicine Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases. Disc Medicine Inc., formerly known as Gemini Therapeutics Inc., is based in WAYLAND, Mass.

Key Statistics

Overview:

Market Capitalization, $K 2,918,830
Enterprise Value, $K 2,754,720
Shares Outstanding, K 37,750
Float, K 36,376
% Float 96.36%
Short Interest, K 3,790
Short Float 10.04%
Days to Cover 4.83
Short Volume Ratio 0.38
% of Insider Shareholders 3.64%
% of Institutional Shareholders 83.70%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -109,360 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -62,320 K
EBIT, $ -203,610 K
EBITDA, $ -208,760 K

Growth:

1-Year Return 39.06%
3-Year Return 232.85%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.77 on 11/06/25
Next Earnings Date 02/26/26 [--]
Earnings Per Share ttm -5.35
EPS Growth vs. Prev Qtr -12.03%
EPS Growth vs. Prev Year -98.88%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/30/22

IRON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -31.61%
Return-on-Assets % -28.96%
Profit Margin % 0.00%
Debt/Equity 0.05
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.80
Book Value/Share 16.38
Interest Coverage -190.23
60-Month Beta 0.87
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar